IMMUNOCHEM THERAPEUTICS LLC
AUBURNDALE, United States · Founded 2018 · $1.2M raised
- Headquarters
- AUBURNDALE, Massachusetts
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Total Funding
- $1.2M
- Last Round
- $1.2M Grant
About
ImmunoChem Therapeutics is a clinical-stage Northwestern University spinout developing brain-penetrant small molecule drugs that suppress neuroinflammation, a key driver of cognitive decline in Alzheimer's disease, brain injury, and stroke. The company has advanced two CNS-penetrant assets into Phase 1 clinical trials, backed by over $4 million in NIH SBIR and STTR grants.
Summary
IMMUNOCHEM THERAPEUTICS LLC is a Biotech company based in AUBURNDALE, United States, founded in 2018. It has raised $1.2M in total.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company